1.
A Dominantly Inherited 5′ UTR Variant Causing Methylation-Associated Silencing of BRCA1 as a Cause of Breast and Ovarian Cancer
by Evans, D.Gareth R
American journal of human genetics, 2018, Vol.103 (2), p.213-220
2.
Clinical and molecular predictors of mortality in neurofibromatosis 2: a UK national analysis of 1192 patients
by Hexter, Adam
Journal of Medical Genetics, 2015, Vol.52 (10), p.699-705
3.
Cranial meningiomas in 411 neurofibromatosis type 2 (NF2) patients with proven gene mutations: clear positional effect of mutations, but absence of female severity effect on age at...
by Smith, Miriam J
Journal of medical genetics, 2011, Vol.48 (4), p.261-265
4.
Frequency of SMARCB1 mutations in familial and sporadic schwannomatosis
by Smith, Miriam J
Neurogenetics, 2012, Vol.13 (2), p.141-145
5.
Genotype-Phenotype Correlations for Nervous System Tumors in Neurofibromatosis 2: A Population-Based Study
by Baser, Michael E
American journal of human genetics, 2004, Vol.75 (2), p.231-239
6.
Predictors of the Risk of Mortality in Neurofibromatosis 2
by Baser, Michael E
American journal of human genetics, 2002, Vol.71 (4), p.715-723
7.
Empirical development of improved diagnostic criteria for neurofibromatosis 2
by Baser, Michael E.
Genetics in medicine, 2011, Vol.13 (6), p.576-581
8.
Cranial meningiomas in 411 NF2 patients with proven gene mutations: Clear positional effect of mutations, but absence of female severity effect on age at onset
by Smith, Miriam Jane
Journal of medical genetics, 2011, Vol.48 (4), p.261
9.
Meta-PCR: A Novel Method for Creating Chimeric DNA Molecules and Increasing the Productivity of Mutation Scanning Techniques
by Wallace, A J
Genetic testing, 1999, Vol.3 (2), p.173-183
10.
Targeting glioma stem cells through combined BMI1 and EZH2 inhibition
by Jin, Xun
Nature medicine, 2017, Vol.23 (11), p.1352-1361
11.
Ricolinostat plus lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: a multicentre phase 1b trial
by Yee, Andrew J, MD
The lancet oncology, 2016, Vol.17 (11), p.1569-1578
12.
The safety of addition of nitrous oxide to general anaesthesia in at-risk patients having major non-cardiac surgery (ENIGMA-II): a randomised, single-blind trial
by Myles, Paul S, Prof
The Lancet (British edition), 2014, Vol.384 (9952), p.1446-1454
13.
Anchored plasticity opens doors for selective inhibitor design in nitric oxide synthase
by Garcin, Elsa D
Nature chemical biology, 2008, Vol.4 (11), p.700-707
14.
Mutagenesis of the NaChBac sodium channel discloses a functional role for a conserved S6 asparagine
by O’Reilly, Andrias O
European biophysics journal, 2017, Vol.46 (7), p.665-674
15.
Effect of body position and ventilation on umbilical artery and venous blood flows during delayed umbilical cord clamping in preterm lambs
by Hooper, Stuart B
Archives of disease in childhood. Fetal and neonatal edition, 2017, Vol.102 (4), p.F312-F319
16.
A predictive model for drug bioaccumulation and bioactivity in Caenorhabditis elegans
by Roy, Peter J
Nature chemical biology, 2010, Vol.6 (7), p.549-557
17.
Lipid interactions of LAH4, a peptide with antimicrobial and nucleic acid transfection activities
by Perrone, Barbara
European biophysics journal, 2014, Vol.43 (10-11), p.499-507
18.
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial
by Joshi, Nikhil V
The Lancet (British edition), 2014, Vol.383 (9918), p.705-713
19.
Imputation of Exome Sequence Variants into Population-Based Samples and Blood-Cell-Trait-Associated Loci in African Americans: NHLBI GO Exome Sequencing Project
by AUER, Paul L
American journal of human genetics, 2012, Vol.91 (5), p.794-808
20.
Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial
by Carman, William F
The Lancet (British edition), 2000, Vol.355 (9198), p.93-97
